Clinical Trial Update: Safety and Immunogenicity of a Monovalent Conjugated Vaccine Against Haemophilus Influenzae Type b [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and immunogenicity of a monovalent Haemophilus influenzae type b conjugate vaccine has completed. The sponsor is Novartis Vaccin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilus Influenzae Type Infection

Drugs mentioned

• Monovalent Haemophilus influenzae type b conjugate vaccine (Haemophilus influenzae type b conjugate vaccine)

Snippet

Sponsor: Novartis Vaccines | Conditions: Haemophilus Influenzae Type b | Phase 3 | Status: COMPLETED